Chemoinformaics analysis of 13-alpha-Hydroxymultiflorine
Molecular Weight | 262.353 | nRot | 0 |
Heavy Atom Molecular Weight | 240.177 | nRig | 21 |
Exact Molecular Weight | 262.168 | nRing | 4 |
Solubility: LogS | -1.057 | nHRing | 4 |
Solubility: LogP | 0.533 | No. of Aliphatic Rings | 4 |
Acid Count | 0 | No. of Aromatic Rings | 0 |
Base Count | 1 | No. of Aliphatic Carbocycles Rings | 0 |
Atoms Count | 41 | No. of Aliphatic Hetero Cycles | 4 |
No. of Heavy Atom | 19 | No. of Aromatic Carbocycles | 0 |
nHetero | 4 | No. of Aromatic Hetero Cycles | 0 |
nBridge Head | 2 | No. Saturated Carbocycles | 0 |
No. of Hydrogen atom | 22 | No. of Saturated Hetero Cycles | 3 |
No. of Carbon atom | 15 | No. of Saturated Rings | 3 |
No. of Nitrogen atom | 2 | No. of Arom Atom | 0 |
No. of Oxygen atom | 2 | No. of Arom Bond | 0 |
nHA | 4 | APOL | 43.5234 |
nHD | 1 | BPOL | 26.3586 |
QED | 0.695 |
Synth | 5.117 |
Natural Product Likeliness | 2.047 |
NR-PPAR-gamma | 0.003 |
Lipinski | Accepted |
Pfizer | Accepted |
GSK | Accepted |
Golden Triangle | Accepted |
Pgp-inh | 0 |
Pgp-sub | 0.998 |
HIA | 0.085 |
CACO-2 | -5.069 |
MDCK | 0.0000269 |
BBB | 0.385 |
PPB | 0.170165 |
VDSS | 1.483 |
FU | 0.835232 |
CYP1A2-inh | 0.016 |
CYP1A2-sub | 0.067 |
CYP2c19-inh | 0.028 |
CYP2c19-sub | 0.817 |
CYP2c9-inh | 0.006 |
CYP2c9-sub | 0.068 |
CYP2d6-inh | 0.018 |
CYP2d6-sub | 0.537 |
CYP3a4-inh | 0.012 |
CYP3a4-sub | 0.298 |
CL | 15.036 |
T12 | 0.713 |
hERG | 0.024 |
Ames | 0.15 |
ROA | 0.024 |
SkinSen | 0.963 |
Carcinogencity | 0.932 |
EI | 0.884 |
Respiratory | 0.966 |
NR-Aromatase | 0.004 |
Antiviral | Yes |
Prediction | 0.754697 |